EXHIBIT B REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of June 6, 2003, by and among Cytogen Corporation, a Delaware corporation (the "Company"), and the investors signatory hereto...Registration Rights Agreement • June 9th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
EXHIBIT NO. 10.2 NOTE PURCHASE AGREEMENT NOTE PURCHASE AGREEMENT dated as of July 21, 1997, between Cytogen Corporation, a Delaware corporation (the "Company"), and Elan International Services, Ltd., a Bermuda corporation (the "Purchaser"). R E C I T...Note Purchase Agreement • August 6th, 1997 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
Exhibit 10.16.3 SECOND AMENDMENT TO OPTION AGREEMENT ------------------------------------ This Second Amendment to the Option Agreement dated as of May 6, 1994 (the "Original Agreement") by and between CYTOGEN CORPORATION, a Delaware corporation (the...Option Agreement • March 28th, 1996 • Cytogen Corp • In vitro & in vivo diagnostic substances
ARTICLE I. DEFINITIONSShare Purchase Agreement • November 7th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 14th, 2005 • Cytogen Corp • Pharmaceutical preparations • New York
AGREEMENT OF SUBSTITUTION AND AMENDMENT OF RIGHTS AGREEMENTRights Agreement • September 2nd, 2004 • Cytogen Corp • Pharmaceutical preparations
EXHIBIT 10.1 FIRST AMENDMENT TO LEASE THIS AGREEMENT (hereinafter referred to as the "Amendment") made as of the16 day of March 2001, between 826 NEWTOWN ASSOCIATES, L.P., a Delaware limited partnership, whose address is C/O First Evergreen, 101...Lease • May 14th, 2001 • Cytogen Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.1 AMENDMENT NUMBER 1 TO LIMITED LIABILITY COMPANY AGREEMENT OF PSMA DEVELOPMENT COMPANY LLC This Amendment Number 1 is made this 22nd day of March, 2002 by and between Progenics Pharmaceuticals, Inc., a Delaware corporation ("Progenics"),...Limited Liability Company Agreement • May 14th, 2002 • Cytogen Corp • In vitro & in vivo diagnostic substances
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 6 OF THIS WARRANT -------------------------------------------------------Warrant Agreement • December 16th, 2004 • Cytogen Corp • Pharmaceutical preparations • New Jersey
COMMON STOCK PURCHASE AGREEMENT Dated as of October 4, 2000 by and between CYTOGEN CORPORATIONCommon Stock Purchase Agreement • October 12th, 2000 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
ARTICLE I. DEFINITIONSSecurities Purchase Agreement • July 11th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances • Delaware
Background ----------Severance Agreement • March 24th, 1997 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
RECITALSAssignment Agreement • November 12th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances • Delaware
OFLimited Liability Company Agreement • July 20th, 1999 • Cytogen Corp • In vitro & in vivo diagnostic substances • Delaware
SUBLEASE --------Sublease • August 14th, 2002 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
Exhibit 10.2 THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES...Securities Agreement • July 11th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances
This Agreement is made the 21st day of July 1997 BY AND BETWEEN ELAN CORPORATION, plc An Irish company, having its registered office at Lincoln House, Lincoln Place, Dublin 2, Ireland. AND TARGON CORPORATION A Delaware corporation, having an office at...Licensing Agreement • August 6th, 1997 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS MANUFACTURING AGREEMENT MANUFACTURING AGREEMENT, dated September 29, 2006, by and between CYTOGEN CORPORATION, a Delaware...Manufacturing Agreement • November 9th, 2006 • Cytogen Corp • Pharmaceutical preparations • New Jersey
ADDENDUM NO. 2 TO STOCK EXCHANGE AGREEMENT AMONG CYTOGEN CORPORATION AND THE STOCKHOLDERS AND DEBTHOLDERS OF PROSTAGEN, INC.Stock Exchange Agreement • November 22nd, 2004 • Cytogen Corp • Pharmaceutical preparations
EXHIBIT 10.2Registration Rights Agreement • December 23rd, 1997 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of July 10, 2003, by and among Cytogen Corporation, a Delaware corporation (the "Company"), and the investors signatory hereto...Registration Rights Agreement • July 11th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances • Delaware
ADOPTION AGREEMENT FOR MFS FUND DISTRIBUTORS, INC. NON-STANDARDIZED 401(K) PROFIT SHARING PLAN AND TRUSTAdoption Agreement • April 27th, 2001 • Cytogen Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.25 STRATEGIC ALLIANCE AGREEMENT ---------------------------- This Agreement, dated September 15, 1999 ("Effective Date") is made between InforMax, Inc. ("InforMax"), a Delaware corporation doing business at 6010 -------- Executive...Strategic Alliance Agreement • March 28th, 2000 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
Background ----------Severance Agreement • March 28th, 1996 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
Exhibit 10.32 DISTRIBUTION AGREEMENT ---------------------- This Agreement is made as of this 22nd day of December, 1995 by and between CYTOGEN CORPORATION, a Delaware corporation having its principal place of business at 600 College Road East,...Distribution Agreement • March 28th, 1996 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
R E C I T A L S: ----------------Note Purchase Agreement • August 6th, 1997 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 2nd, 2007 • Cytogen Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 28, 2007, between Cytogen Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 2nd, 2007 • Cytogen Corp • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 28, 2007, between Cytogen Corporation, a Delaware corporation (the “Company”) and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
EXHIBIT 10.1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTConvertible Preferred Stock Purchase Agreement • December 23rd, 1997 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
LICENSE AGREEMENT BY AND BETWEEN CYTOGEN CORPORATION AND BERLEX LABORATORIES, INC.License Agreement • November 13th, 1998 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
RECITALS --------Exclusive Distribution Agreement • May 10th, 2006 • Cytogen Corp • Pharmaceutical preparations • New Jersey
MEMBERSHIP INTEREST PURCHASE AGREEMENT by and between PROGENICS PHARMACEUTICALS, INC.Membership Interest Purchase Agreement • May 10th, 2006 • Cytogen Corp • Pharmaceutical preparations • Delaware
BETWEEN:License and Distribution Agreement • March 30th, 2001 • Cytogen Corp • In vitro & in vivo diagnostic substances • Ontario
EXHIBIT 10.5 TERMINATION AGREEMENT THIS TERMINATION AGREEMENT (this "Agreement") is made as of the 16th day of June, 2003, by and among Berlex Laboratories, Inc., a Delaware corporation, with offices at 340 Changebridge Road, P.O. Box 1000, Montville,...Termination Agreement • November 12th, 2003 • Cytogen Corp • In vitro & in vivo diagnostic substances • New Jersey
AGREEMENTResearch and Development • March 28th, 1996 • Cytogen Corp • In vitro & in vivo diagnostic substances • New York
